Skip to contentSkip to sidebarSkip to footer
OmniStem
Menu Close
  • Home
  • About
    • About Us
    • Our Team
    • Patient Reviews
    • Punta Cana Experience
  • Therapies
    • Cell-based Therapies
      • Stem Cell Therapy
      • Exosome Therapy
      • NeuroBoost
      • PRGF Plasma Rich in Growth Factors
    • Supportive Therapies
      • Hyperbaric Oxygen Therapy (HBOT)
      • Colon Hydrotherapy
      • Ozone Therapy
      • Physiotherapy
    • Areas of Clinical Focus
      • Healthy Aging & Longevity
      • Joint Pain & Sport Injuries
      • Back Pain & Spine Disorders
      • Autoimmune Conditions
      • Neurological & Cognitive Support
      • Pulmonary Health
      • Hair Loss (Alopecia)
      • Sexual Health
  • Testimonials
  • Resources
    • What Are Stem Cells
    • Sources & Standards
    • Glossary
    • FAQs
    • OmniStem Blog
  • Contact
Close
  • Home
  • About
    • About Us
    • Our Team
    • Patient Reviews
    • Punta Cana Experience
  • Therapies
    • Cell-based Therapies
      • Stem Cell Therapy
      • Exosome Therapy
      • NeuroBoost
      • PRGF Plasma Rich in Growth Factors
    • Supportive Therapies
      • Hyperbaric Oxygen Therapy (HBOT)
      • Colon Hydrotherapy
      • Ozone Therapy
      • Physiotherapy
    • Areas of Clinical Focus
      • Healthy Aging & Longevity
      • Joint Pain & Sport Injuries
      • Back Pain & Spine Disorders
      • Autoimmune Conditions
      • Neurological & Cognitive Support
      • Pulmonary Health
      • Hair Loss (Alopecia)
      • Sexual Health
  • Testimonials
  • Resources
    • What Are Stem Cells
    • Sources & Standards
    • Glossary
    • FAQs
    • OmniStem Blog
  • Contact
Apply Now
OmniStem
  • Home
  • About
    • About Us
    • Our Team
    • Patient Reviews
    • Punta Cana Experience
  • Therapies
    • Cell-based Therapies
      • Stem Cell Therapy
      • Exosome Therapy
      • NeuroBoost
      • PRGF Plasma Rich in Growth Factors
    • Supportive Therapies
      • Hyperbaric Oxygen Therapy (HBOT)
      • Colon Hydrotherapy
      • Ozone Therapy
      • Physiotherapy
    • Areas of Clinical Focus
      • Healthy Aging & Longevity
      • Joint Pain & Sport Injuries
      • Back Pain & Spine Disorders
      • Autoimmune Conditions
      • Neurological & Cognitive Support
      • Pulmonary Health
      • Hair Loss (Alopecia)
      • Sexual Health
  • Testimonials
  • Resources
    • What Are Stem Cells
    • Sources & Standards
    • Glossary
    • FAQs
    • OmniStem Blog
  • Contact
best stem cell clinic in 2026
Stem Cell Therapy Cost

Finding the Best Stem Cell Therapy Clinics in 2026: A Complete Guide

May 24, 20260Comments
How to choose a stem cell clinic Search for stem cell therapy and you will find clinics in the U.S. and abroad describing similar treatments…
UC-MSC and Exosomes
Regenerative Medicine

The Roles of UC-MSCs and Exosomes

September 15, 20250Comments
UC-MSCs and exosomes: how they differ OmniStem uses two biologics: umbilical cord mesenchymal stem cells (UC-MSCs) and the exosomes those cells release. They are related,…
stem cells for ACL Tear
Regenerative Medicine

Are UC-MSC Stem Cell Therapies Available in the US?

September 15, 20250Comments
Are UC-MSC therapies available in the U.S.? Not as a standard treatment. No umbilical cord mesenchymal stem cell (UC-MSC) product has FDA approval, so a…
Stem Cells Personalized Care
Regenerative Medicine

Stem Cells for Personalized Care

September 15, 20250Comments
What personalized stem cell therapy means "Personalized" can mean two very different things in stem cell therapy. In research labs, it can mean cells made…
Different Types of Stem Cells
Medical Research

Different Types of Stem Cells: A Guide to Their Functions and Medical Potential

May 25, 20250Comments
Types of stem cells, explained What makes a cell a stem cell? Two abilities: it can copy itself (self-renewal), and it can give rise to…
Mesenchymal Stem Cells Guide
Medical Research

Mesenchymal Stem Cells Complete Guide

March 26, 20250Comments
Mesenchymal stem cells: a complete guide Mesenchymal stem cells (MSCs) are the cells used in most stem cell therapy outside of blood transplants, including the…

Mesenchymal stem cells: a complete guide

Mesenchymal stem cells (MSCs) are the cells used in most stem cell therapy outside of blood transplants, including the umbilical cord cells OmniStem uses. This guide explains how scientists define them, where they come from, how they act in the body, and where their use is approved or still being tested.

What MSCs are

MSCs are adult stem cells found in connective tissues such as bone marrow, fat, and umbilical cord. Like all stem cells, they can copy themselves (self-renewal) and give rise to more specialized cells (differentiation). They are multipotent: in the laboratory, they reliably form bone, cartilage, and fat cells.

The name comes from the mesenchyme, the loose connective tissue of the early embryo that later forms bone, cartilage, muscle, fat, and blood vessels. Many researchers now prefer the term mesenchymal stromal cells, because not every cell in an MSC preparation meets the strict definition of a stem cell. The abbreviation stays the same.

How scientists define an MSC

In 2006, the International Society for Cellular Therapy (ISCT) set three minimum criteria that a cell population must meet to be called MSCs. These criteria let laboratories around the world compare their work.

  1. The cells stick to plastic when grown in standard culture conditions.
  2. At least 95% of the cells carry the surface markers CD105, CD73, and CD90, and no more than 2% carry markers of blood cells (CD45, CD34, CD14 or CD11b, CD79α or CD19, and HLA-DR).
  3. The cells can form bone, fat, and cartilage cells in the laboratory.
Meeting these criteria is a baseline. Laboratories that prepare cells for treatment also test each batch for viability, sterility, and cell count.

How MSCs act in the body

Early researchers expected MSCs to repair tissue by turning into new cells. Some laboratory studies have reported MSCs forming cell types outside their usual range, such as nerve or liver cells, but whether this happens in the body, and whether it matters for treatment, is disputed.

Later work changed the picture. Few infused MSCs survive in the body for long, and most of their effect comes from the molecules they release. In laboratory and animal studies, these signals lower inflammation, adjust immune cell activity, support the growth of new blood vessels, and limit scarring. For this reason, Arnold Caplan, the scientist who named MSCs, proposed in 2017 calling them medicinal signaling cells. Much of this signaling travels in exosomes, tiny vesicles that cells use to communicate.

MSCs and the immune system

MSCs carry low levels of the surface molecules that trigger immune rejection. That is why cells from one screened donor can be given to a different patient, which is called allogeneic use.

Low immunogenicity is not the same as invisibility. Researchers describe MSCs as immune evasive rather than immune privileged: the immune system can still recognize and clear donor cells over time. This is one reason their effects are attributed to the signals they release in the window before they are cleared.

electron microscopy image of a mesenchymal stem cell
Electron microscopy image of a mesenchymal stem cell showing characteristic ultrastructural features

Where MSCs come from

Source How cells are collected Notes
Bone marrow Needle aspiration, usually from the pelvis The most studied source. Requires a procedure on the patient or donor
Fat (adipose) tissue Liposuction Yields many cells. Requires a procedure
Umbilical cord tissue From the cord's Wharton's jelly, after birth, with consent No procedure on mother or baby. The tissue would otherwise be discarded
Placenta After birth, with consent Less studied than cord tissue
Dental pulp From extracted teeth Mainly a research source
Synovial fluid and membrane From the joint lining Mainly a research source

Umbilical cord MSCs

Umbilical cord MSCs (UC-MSCs) come from Wharton’s jelly, the soft connective tissue inside the cord. In laboratory comparisons with bone marrow MSCs, they divide faster and keep their properties through more rounds of expansion. Because they come from a screened donor, the patient needs no harvesting procedure. Our guide to the types of stem cells compares them with other stem cells, and our sources and standards page explains how OmniStem’s cells are sourced.

MSCs and hematopoietic stem cells

Hematopoietic stem cells (HSCs) are the other adult stem cells most often used in medicine. They are easy to confuse with MSCs, especially because both are found in bone marrow and umbilical cord.
Mesenchymal stem cells (MSCs) Hematopoietic stem cells (HSCs)
What they form Bone, cartilage, fat, and connective tissue cells All blood and immune cells
Main sources Bone marrow, fat, umbilical cord tissue Bone marrow, mobilized blood, umbilical cord blood
Main medical use Research and approved uses in immune conditions. Widely studied in tissue repair Bone marrow and cord blood transplants for blood cancers and blood disorders
Effect on the immune system Adjust immune activity Rebuild the immune system after a transplant

Where MSC therapy is approved

A small number of MSC products have regulatory approval, all for graft-versus-host disease, a complication of bone marrow transplants. In Japan, Temcell, made from bone marrow MSCs, was approved in 2015. In the United States, the FDA approved Ryoncil, also from bone marrow MSCs, in December 2024 for children with steroid-refractory acute graft-versus-host disease. No umbilical cord MSC product has FDA approval.

Where MSC therapy is being studied

Thousands of clinical trials have registered MSC treatments. The evidence differs widely by condition.

In knee osteoarthritis, randomized trials, including one using UC-MSCs, have reported less pain than with hyaluronic acid, without clear changes in cartilage on MRI. In autoimmune conditions such as rheumatoid arthritis, lupus, Crohn’s disease, and multiple sclerosis, trials are mostly small and their results mixed. In neurological conditions such as stroke, Parkinson’s disease, ALS, and spinal cord injury, most trials are early-phase and focused on safety. MSCs are also being studied in lung disease, liver disease, diabetes, and chronic wounds.

Outside the approved uses, MSC therapy is investigational. Our medical team evaluates UC-MSC protocols in the areas of clinical focus listed on our site, case by case.

Safety and open questions

A 2021 meta-analysis of 62 randomized trials with 3,546 participants linked MSC treatment to transient fever, administration-site reactions, constipation, fatigue, and sleeplessness. A 2020 meta-analysis found no increased risk of infection, blood clots, death, or malignancy.

Researchers still face several open problems. MSCs from different sources and laboratories behave differently, which makes trials hard to compare. Isolation and expansion methods are not standardized, and the best dose and route for most conditions are unknown. Large, well-controlled trials are still needed for most uses.

Start with a medical review

Whether UC-MSC therapy fits your case is a medical decision. At OmniStem, it starts with a physician reviewing your records through the Regenerative Evaluation.

Start Your Evaluation
Scientific References
  1. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.

  2. Caplan AI. Mesenchymal stem cells: time to change the name! Stem Cells Translational Medicine. 2017;6(6):1445-1451.

  3. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nature Biotechnology. 2014;32(3):252-260.

  4. Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells International. 2016;2016:6901286.

  5. Matas J, Orrego M, Amenabar D, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Translational Medicine. 2019;8(3):215-224.

  6. Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Research & Therapy. 2021;12:545.

  7. Thompson M, Mei SHJ, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. eClinicalMedicine. 2020;19:100249.

OmniStem

OmniStem is a regenerative medicine center in Punta Cana, Dominican Republic, providing clinician-guided regenerative and supportive therapies.

Instagram Facebook Whatsapp
Asociación Dominicana de Turismo de Salud
better omnistem
Punta Cana Clinic
  • Boulevard Turistico del Este, Plaza Cormont II, Local 101, Punta Cana. Dominican Republic.
  • info@omnistem.com
  • +1 (786) 475 3675
  • +1 (809) 833 4510
WhatsApp
Explore More
  • About Us
  • Our Team
  • Punta Cana Experience
  • Testimonials
  • Resource Center
  • Blog
  • Privacy Policy
  • Terms and conditions
Sign up for our Newsletter
Newsletter Form
better medical tourism
Asociación Dominicana de Turismo de Salud
OmniStem does not claim to diagnose or cure specific medical conditions. All regenerative protocols are administered under physician supervision and designed to support the body’s natural biological processes under physician oversight. Outcomes vary by individual and are not guaranteed. All biologics are ethically sourced with documented informed consent and complete donor-to-patient traceability. Regenerative medicine is an evolving field; evidence varies by indication and application. All therapies require medical evaluation prior to administration.

© 2026 OmniStem